HomeAKP • FRA
add
Anika Therapeutics Inc
Previous close
€26.40
Day range
€23.40 - €23.40
Year range
€15.80 - €26.40
Market cap
380.05M USD
Avg Volume
7.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 42.97M | 8.45% |
Operating expense | 1.92M | -93.77% |
Net income | -63.00M | -1,183.62% |
Net profit margin | -146.61 | -1,083.29% |
Earnings per share | 0.05 | 123.81% |
EBITDA | 27.98M | 1,247.79% |
Effective tax rate | 0.32% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 72.87M | -15.59% |
Total assets | 270.63M | -22.48% |
Total liabilities | 58.37M | -8.18% |
Total equity | 212.26M | — |
Shares outstanding | 14.66M | — |
Price to book | 1.82 | — |
Return on assets | 20.38% | — |
Return on capital | 22.55% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -63.00M | -1,183.62% |
Cash from operations | 3.64M | 656.34% |
Cash from investing | -1.84M | 27.24% |
Cash from financing | 342.00K | -48.73% |
Net change in cash | 2.22M | 252.83% |
Free cash flow | 19.41M | 2,912.41% |
About
Founded
1983
Headquarters
Website
Employees
357